A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control

Assoumou, Lambert; Weiss, Laurence; Piketty, Christophe; More

AIDS . 29(15):2003-2007, September 24, 2015.

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection

Weiss, Laurence; Chevalier, Mathieu F.; Assoumou, Lambert; More

AIDS . 28(11):1683-1687, July 17, 2014.

Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART

Piketty, Christophe; Cochand-Priollet, Béatrice; Lanoy, Emilie; More

AIDS . 27(3):401-406, January 28, 2013.

Reply to comment on ‘pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients’

Barrail-Tran, Aurélie; Yazdanpanah, Yazdan; Goldwirt, Lauriane; More

AIDS . 25(7):1011-1012, April 24, 2011.

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients

Barrail-Tran, Aurélie; Yazdanpanah, Yazdan; Goldwirt, Lauriane; More

AIDS . 24(16):2581-2583, October 23, 2010.

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

Charpentier, Charlotte; Laureillard, Didier; Piketty, Christophe; More

AIDS . 24(6):867-873, March 27, 2010.

Characteristics of non-Hodgkin lymphoma arising in HIV-infected patients with suppressed HIV replication

Gérard, Laurence; Meignin, Véronique; Galicier, Lionel; More

AIDS . 23(17):2301-2308, November 13, 2009.

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

Piketty, Christophe; Selinger-Leneman, Hana; Grabar, Sophie; More

AIDS . 22(10):1203-1211, June 19, 2008.

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

Serpaggi, Jeanne; Chaix, Marie-Laure; Batisse, Dominique; More

AIDS . 20(2):233-240, January 9, 2006.

Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures

Piketty, Christophe; Gérard, Laurence; Chazallon, Corine; More

AIDS . 18(10):1469-1471, July 2, 2004.

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

Landau, Alain; Batisse, Dominique; Piketty, Christophe; More

AIDS . 15(16):2149-2155, November 9, 2001.

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

Landau, Alain; Batisse, Dominique; Huyen, Jean Paul Duong Van; More

AIDS . 14(7):839-844, May 5, 2000.

Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including...

Piketty, Christophe; Race, Esther; Castiel, Philippe; More

AIDS . 14(5):626-628, March 31, 2000.

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease...

Piketty, Christophe; Race, Esther; Castiel, Philippe; More

AIDS . 13(11):F71-F77, July 30, 1999.

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

Piketty, Christophe; Castiel, Philippe; Belec, Laurent; More

AIDS . 12(7):745-750, May 7, 1998.